Ascend Laboratories recalls over 140,000 bottles of generic Lipitor nationwide

Over 140,000 bottles of a cholesterol medication have been recalled due to failed dissolution specifications. Ascend Laboratories is recalling Atorvastatin Calcium, a generic version of Lipitor, distributed nationwide. The recall affects tablets with expiration dates up to February 2027. The FDA classified this as a Class II recall, meaning potential adverse health consequences are temporary and reversible, with serious outcomes being remote.